Loading...

PE/Cyanine7 anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_PECy7_042706
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) PE/Cyanine7 (filled histogram) or rat IgG2b, κ PE/Cyanine7 isotype control (open histogram) (gated on total cells).
  • M1slash70_PECy7_042706
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) PE/Cyanine7 (filled histogram) or rat IgG2b, κ PE/Cyanine7 isotype control (open histogram) (gated on total cells).
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
101215 25 µg £60
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101216 100 µg £145
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Hatzi K, et al. 2019. Nat Immunol. 20:86. PubMed
  2. Tran NT, et al. 2019. Cell Rep. 28:3510. PubMed
  3. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  4. Okunuki Y, et al. 2018. Proc Natl Acad Sci U S A. 115:E6264. PubMed
  5. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  6. Wang L, et al. 2021. J Nanobiotechnology. 19:56. PubMed
  7. Kuo PC, et al. 2021. Brain Commun. 3:fcab187. PubMed
  8. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  9. Cheresh P, et al. 2021. Int J Mol Sci. 22:. PubMed
  10. Deng R, et al. 2022. Adv Sci (Weinh). 9:e2103343. PubMed
  11. Odom CV, et al. 2021. J Immunol. 207:1891. PubMed
  12. Parsons M, et al. 2014. J Immunol. 192:1361. PubMed
  13. Tebartz C, et al. 2015. J Immunol. 194:1100. PubMed
  14. Quispe Calla N, et al. 2016. Sci Rep. 6:37723. PubMed
  15. D'Alessandro G, et al. 2020. Eur J Immunol. 50:705. PubMed
  16. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
  17. Gogoi H, et al. 2020. Front Immunol. 1.620833333. PubMed
  18. Liu K, et al. 2021. Cell Metabolism. 33(3):666-675.e4. PubMed
  19. Giorgetti E, et al. 2020. Cell Reports. 29(6):1539-1554.e7.. PubMed
  20. Thelin MA, et al. 2017. Diabetes. 66:2220. PubMed
  21. Zhang LJ, et al. 2019. Immunity. 50:121. PubMed
  22. Abels ER et al. 2019. Cell Rep. 28(12):3105-3119 . PubMed
  23. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  24. Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
  25. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  26. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  27. McGill BE et al. 2018. The Journal of Neuroscience. 38(1):200-219 . PubMed
  28. Kitagawa S, et al. 2022. NPJ Vaccines. 7:115. PubMed
  29. Rodrigues M, et al. 2022. Biochem J. 479:1891. PubMed
  30. Jung MY, et al. 2022. Neurooncol Adv. 4:vdac017. PubMed
  31. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  32. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  33. Sharma GP, et al. 2021. PLoS One. 16:e0259042. PubMed
  34. Li Z, et al. 2021. Immunology. 163:105. PubMed
  35. Correa S, et al. 2020. ACS Nano. 14:2224. PubMed
  36. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  37. Gazit R, et al. 2014. J Exp Med. 211:1315. PubMed
  38. Kurelac I, et al. 2019. Nat Commun. 10:903. PubMed
  39. Kobayashi Y, et al. 2018. PLoS One. 13:e0195008. PubMed
  40. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  41. Wei H, et al. 2021. Malar J. 20:89. PubMed
  42. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 5:64. PubMed
  43. Hickey A, et al. 2021. Front Microbiol. 12:653587. PubMed
  44. Morgan PK, et al. 2021. J Biol Chem. 297:101341. PubMed
  45. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  46. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  47. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  48. Chen T, et al. 2021. JCI Insight. 6:. PubMed
  49. Radovanovic I, et al. 2014. J Immunol. 193:1290. PubMed
  50. Zasłona Z, et al. 2014. J Immunol. 193:4245. PubMed
  51. Zheng W, et al. 2021. Wellcome Open Research. 6:52. PubMed
  52. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  53. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  54. Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed
  55. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  56. Saggu G, et al. 2018. Nat Commun. 9:5058. PubMed
  57. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  58. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  59. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  60. Deslyper G, et al. 2021. Parasitology. 148:539. PubMed
  61. Shen H, et al. 2015. Infect Immun . 83: 2694 - 2704. PubMed
  62. Akhmetzyanova ER, et al. 2019. Front Cell Neurosci. 12:507. PubMed
  63. Lubkin A et al. 2019. Cell host & microbe. 25(3):463-470 . PubMed
  64. Gibson EM, et al. 2019. Cell. 176:43:00. PubMed
  65. Juttukonda LJ, et al. 2017. Cell Host Microbe. 22:531. PubMed
  66. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  67. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  68. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  69. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  70. Zong L, et al. 2021. NPJ Aging Mech Dis. 7:25. PubMed
  71. Almutairi F, et al. 2021. Front Immunol. 12:772288. PubMed
  72. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  73. Royzman D, et al. 2022. Front Immunol. 13:1012647. PubMed
  74. Martin R, et al. 2014. J Leukoc Biol. 96:151. PubMed
  75. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  76. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  77. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
  78. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  79. Angelidis I, et al. 2019. Nat Commun. 10:963. PubMed
  80. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  81. Walker FC, et al. 2021. PLoS Pathog. 17:e1009402. PubMed
  82. Johansen AZ, et al. 2022. Pharmaceutics. 14:. PubMed
  83. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  84. Beauchamp EM, et al. 2021. Blood Cancer Discov. 6:. PubMed
  85. Dodagatta-Marri E, et al. 2021. Cell Rep. 36:109309. PubMed
  86. Super M, et al. 2021. Nat Biomed Eng. Online ahead of print. PubMed
  87. Kulkarni NN, et al. 2021. J Biol Chem. 297:100828. PubMed
  88. Jia X, et al. 2021. Front Cell Dev Biol. 9:685522. PubMed
  89. Klopfenstein N, et al. 2021. PLoS Pathog. 17:e1009387. PubMed
  90. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  91. Vazquez S, et al. 2015. Exp Hematol. 43: 578-585. PubMed
  92. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  93. Vasilijevic J, et al. 2017. PLoS Pathog. 13:e1006650. PubMed
  94. Meeks K, et al. 2009. J Immunol. 183:8026. PubMed
  95. Hore ZL, et al. 2021. Wellcome Open Res. 6:68. PubMed
  96. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  97. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  98. Shin JE, et al. 2021. Heliyon. 7:e08433. PubMed
  99. Koh F, et al. 2015. Proc Natl Acad Sci U S A. 112:1734. PubMed
  100. Kohn M, et al. 2021. Front Immunol. 580594:12. PubMed
  101. Liang Z, et al. 2020. Pain. 161:2089. PubMed
  102. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  103. Snell LM, et al. 2018. Immunity. 49:678. PubMed
  104. Amo-Aparicio J, et al. 2021. Theranostics. 11:9805. PubMed
  105. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  106. Goldman E, et al. 2021. Cells. 10:. PubMed
  107. Dokoshi T, et al. 2021. J Clin Invest. 131:. PubMed
  108. Pan YC, et al. 2021. Mol Ther Oncolytics. 20:175. PubMed
  109. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  110. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  111. Kirschbaum K, et al. 2016. Proc Natl Acad Sci U S A. 113: 13227 - 13232. PubMed
  112. Kooreman NG et al. 2018. Cell stem cell. 22(4):501-513 . PubMed
  113. Proto JD et al. 2018. Immunity. 49(4):666-677 . PubMed
  114. Secondini C, et al. 2017. Oncoimmunology. 6:e1316437. PubMed
  115. Huang YL, et al. 2021. Commun Biol. 4:229. PubMed
  116. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  117. Synn CB, et al. 2022. Clin Transl Immunology. 11:e1364. PubMed
  118. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  119. Gomzikova MO, et al. 2020. Sci Rep. 10:10740. PubMed
  120. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  121. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  122. Gozgit JM, et al. 2021. Cancer Cell. :. PubMed
  123. Suresh MV, et al. 2019. JCI Insight. 4:e133103. PubMed
  124. Patel S, et al. 2019. Viruses. 0.877083333. PubMed
  125. Bradley KC, et al. 2019. Cell Rep. 28:245. PubMed
  126. Kumar MP, et al. 2018. Cell Rep. 25:1458. PubMed
  127. Steuerman Y et al. 2018. Cell systems. 6(6):679-691 . PubMed
  128. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  129. Uddin MJ, et al. 2022. Mucosal Immunol. 15:165. PubMed
  130. Wang D, et al. 2021. Nat Commun. 12:2674. PubMed
  131. Jia Q, et al. 2021. Theranostics. 4699:11. PubMed
  132. Dobosz E, et al. 2021. Dis Model Mech. :14. PubMed
  133. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
  134. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  135. Bambouskova M, et al. 2021. Cell Reports. 34(10):108756. PubMed
  136. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  137. Pérez-Girón J, et al. 2015. J Vis Exp. 100: 52803. PubMed
  138. Li Z, et al. 2018. Front Immunol. 9:347. PubMed
  139. Marcus A et al. 2018. Immunity. 49(4):754-763 . PubMed
  140. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  141. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  142. Wilson DH, et al. 2020. Nat Commun. 0.767361111. PubMed
  143. Tran NT, et al. 2020. STAR Protocols. 1(1):100028. PubMed
  144. Endoh M, et al. 2020. Cell Reports. 30(6):1823-1834. PubMed
  145. Li H, et al. 2020. Nature. 584:274. PubMed
  146. Sibilio A, et al. 2022. iScience. 25:103790. PubMed
  147. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  148. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  149. Liu H, et al. 2022. Front Pharmacol. 13:949316. PubMed
  150. Boulay A, et al. 2015. J Neurosci. 35:4427. PubMed
  151. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  152. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  153. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  154. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  155. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  156. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  157. Gao C, et al. 2017. Mol Neurobiol.. 10.1007/s12035-016-0318-0. PubMed
  158. Khare P, et al. 2017. J Autoimmun. 10.1016/j.jaut.2017.09.002. PubMed
  159. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  160. Frenis K, et al. 2021. Basic Res Cardiol. 31:116. PubMed
  161. Crouse B, et al. 2020. NPJ Vaccines. 0.277083333. PubMed
  162. Lee L, et al. 2016. PLoS One. 11:e0167693. PubMed
  163. Arce-Cerezo A, et al. 2015. Sci Rep. 5: 1448. PubMed
  164. Ballet R, et al. 2014. PLoS Pathog. 10:1004550. PubMed
  165. Robinett RA et al. 2018. Cell systems. 7(1):41-48 . PubMed
  166. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  167. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  168. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  169. Merrell AJ, et al. 2021. Hepatology. 74:444. PubMed
  170. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  171. Yu W, et al. 2022. Nat Commun. 13:3544. PubMed
  172. Scholz F, et al. 2015. J Immunol. 195: 2335-2342. PubMed
  173. Koelwyn GJ, et al. 2020. Nat Med. 1452:26. PubMed
  174. Kim SJ, et al. 2020. Cell Mol Immunol. 17:728. PubMed
  175. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  176. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  177. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  178. Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed
  179. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  180. Wang S, et al. 2021. Commun Biol. 22:. PubMed
  181. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  182. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  183. Bent EH, et al. 2021. Nat Commun. 12:6218. PubMed
  184. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  185. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  186. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  187. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  188. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  189. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  190. Ivan DC, et al. 2021. Front Immunol. 12:666961. PubMed
  191. Franklin DA, et al. 2020. JCI Insight. 5:. PubMed
  192. Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed
  193. Liu W, et al. 2022. J Clin Invest. 132: . PubMed
  194. Schönberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  195. Njock MS, et al. 2022. J Extracell Vesicles. 11:e12228. PubMed
  196. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  197. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  198. Moro T, et al. 2016. PLoS One. 11: 0146592. PubMed
  199. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  200. Bordas M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  201. Bellomo A, et al. 2020. Immunity. 53(1):127-142.e7. PubMed
  202. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  203. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  204. Beauchamp N, et al. 2010. J Virol. 84:10191. PubMed
  205. Wang Y, et al. 2020. eLife. 9:e57438.. PubMed
  206. Yu L, et al. 2020. Nat Commun. 2.045833333. PubMed
  207. McKenzie MD, et al. 2019. Cell Stem Cell. 25:258. PubMed
  208. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  209. Contreras NA, et al. 2019. PLoS Pathog. 15:e1007890. PubMed
  210. Cantor DJ et al. 2019. Cell reports. 26(1):108-118 . PubMed
  211. Baratin M, et al. 2017. Immunity. 47:349. PubMed
  212. Coley WD et al. 2018. F1000Research. 2018 Mar 14 [revised 2018 Jan 1] 0.5125. PubMed
  213. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  214. Sadhu S, et al. 2021. J Immunol. 207:1812. PubMed
  215. Sun L, et al. 2022. Adv Sci (Weinh). 9:e2104051. PubMed
  216. Canedo T, et al. 2021. Neuropsychopharmacology. 46:2358. PubMed
  217. Johnson RM, et al. 2021. Front Immunol. 11:614697. PubMed
  218. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  219. Gourvest M, et al. 2021. Leukemia. . PubMed
  220. Bagati A, et al. 2020. Cancer Cell. 39(1):54-67.e9. PubMed
  221. Gicheva N, et al. 2016. Biochem Biophys Res Commun. 479:1-4. PubMed
  222. Asada S, et al. 2018. Nat Commun. 9:2733. PubMed
  223. Kong XF, et al. 2018. Nat Immunol. 19:973. PubMed
  224. Rosen DA, et al. 2019. Sci Transl Med. 11:eaau5266. PubMed
  225. Dokoshi T, et al. 2020. Cell Rep. 30:61. PubMed
  226. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 0.252777778. PubMed
  227. Süß P, et al. 2020. Cell Reports. 30(12):4082-4095. PubMed
  228. Shi J, et al. 2022. Front Pharmacol. 12:818326. PubMed
  229. McPhee C, et al. 2013. J Immunol. 191:4581. PubMed
  230. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  231. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  232. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  233. Shin M, et al. 2020. Cell Chem Biol. 314:27. PubMed
  234. Kaiser S, et al. 2020. Glia. 68:2427. PubMed
  235. Aggio-Bruce R, et al. 2020. Mol Neurobiol. . PubMed
  236. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  237. Molgora M, et al. 2020. Cell. 182:886. PubMed
  238. Alfaro M, et al. 2008. Proc Natl Acad Sci U S A. 105:18366. PubMed
  239. Walker JA, et al. 2020. Immunity. 51(1):104-118. PubMed
  240. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  241. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  242. Liu G, et al. 2022. Theranostics. 12:2248. PubMed
  243. Fan HH, et al. 2021. Methods Mol Biol. 2276:203. PubMed
  244. Monteiro LB, et al. 2020. MethodsX. 7:100938. PubMed
  245. Rodriguez-Tirado C, et al. 2022. Cancers (Basel). 14:. PubMed
  246. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  247. Harding CL, et al. 2020. Front Cell Infect Microbiol. 10:328. PubMed
  248. Chavez JS, et al. 2022. Cells. 11:. PubMed
  249. Boulch M, et al. 2021. Sci Immunol. 6:. PubMed
  250. Gao P, et al. 2020. Front Immunol. 1.636111111. PubMed
  251. Chen S, et al. 2015. Cancer Res . 7: 519-531. PubMed
  252. Groppa E, et al. 2015. EMBO Mol Med. 2015; 7: 1366 - 1384. PubMed
  253. Gharib S, et al. 2014. J Leukoc Biol. 95:9. PubMed
  254. Saul S, et al. 2019. J Leukoc Biol. N/A. PubMed
  255. Severe N et al. 2019. Cell Stem Cell. 25(4):570-583 . PubMed
  256. Boguslawski KM, et al. 2020. Sci Adv. 6:eaax7515. PubMed
  257. Wang L, et al. 2020. J Nanobiotechnology. 18:38. PubMed
  258. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  259. Franklin R, et al. 2022. Nat Commun. 13:2350. PubMed
  260. Gawish R, et al. 2022. Elife. 11:. PubMed
  261. Akhand SS, et al. 2020. Cancer Immunol Res. 8:1542. PubMed
  262. Xu G, et al. 2015. Free Radic Biol Med. 87: 15-25. PubMed
  263. Zhang S, et al. 2016. PLoS Pathog. 12: 1005617. PubMed
  264. Maas SLN, et al. 2020. J Neuroinflammation. 17:120. PubMed
  265. Qi S, et al. 2020. Theranostics. 10:1814. PubMed
  266. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed
  267. Lalor R, et al. 2019. Nutrients. 11. PubMed
  268. Cai T, et al. 2022. Front Immunol. 13:1009932. PubMed
  269. Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed
  270. Zhang Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  271. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  272. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  273. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  274. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  275. Young K, et al. 2021. Cell Stem Cell. . PubMed
  276. Lucas ED, et al. 2020. Cell Reports. 33(2):108258. PubMed
  277. Zysset D, et al. 2016. Nat Commun. 7:13151. PubMed
  278. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
RRID
AB_312798 (BioLegend Cat. No. 101215)
AB_312799 (BioLegend Cat. No. 101216)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Spark PLUS UV™ 395 anti-mouse/human CD11b M1/70 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account